SAM
AVXL icon

Smartleaf Asset Management’s Anavex Life Sciences AVXL Stock Holding History

Smartleaf Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.05K Hold
1,941
– – ﹤0.01% 2678
2026
Q1 		$5.47K Buy
1,941
+1,035
+114% +$4.48K ﹤0.01% 2615
2025
Q4 		$3.44K Buy
906
+23
+3% +$141 ﹤0.01% 2824
2025
Q3 		$7.64K Buy
+883
New +$8.96K ﹤0.01% 2218
2025
Q2 		– Sell
-184
Closed -$1.6K – 2742
2025
Q1 		$1.6K Buy
184
+128
+229% +$1.21K ﹤0.01% 2519
2024
Q4 		$618 Sell
56
-128
-70% -$985 ﹤0.01% 2752
2024
Q3 		$1.04K Buy
184
+128
+229% +$738 ﹤0.01% 2647
2024
Q2 		$240 Buy
+56
New +$227 ﹤0.01% 2659

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Smartleaf Asset Management's AVXL Position: Q2 2026 in Review

Smartleaf Asset Management held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 1,941 shares worth $5.05K. The position accounts for ﹤0.01% of the portfolio, ranked #2678.

Smartleaf Asset Management first reported a position in AVXL in Q2 2024 and has held it in 8 quarters since. The position peaked at $7.64K in Q3 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Smartleaf Asset Management held 1,941 shares of Anavex Life Sciences worth $5.05K as of Q2 2026.
  • Smartleaf Asset Management left its Anavex Life Sciences share count unchanged in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2678 holding.
  • Smartleaf Asset Management first reported a position in Anavex Life Sciences in Q2 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's Anavex Life Sciences position peaked at $7.64K in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.